HOME >> MEDICINE >> NEWS
Starting dose of Lexapro as effective as optimally dosed Zoloft in the treatment of depression

NEW YORK, December 10 Forest Laboratories, Inc. (NYSE: FRX) announced today the results of a clinical study, which showed that LexaproTM (escitalopram oxalate) is as effective and well tolerated as Zoloft (sertraline hydrochloride). The purpose of the study was to evaluate whether the starting dose of Lexapro, 10 mg per day, could provide comparable efficacy to the full dosing range of Zoloft, 50 200 mg per day. Study results showed that patients receiving a dose of 10 mg per day of Lexapro experienced similar efficacy compared to patients receiving a median dose of Zoloft of 150 mg per day. At week four, 46 percent of Zoloft-treated patients received 150 mg per day or higher, and at week eight, 65 percent received 150 mg per day or higher. To achieve a dose of 150 mg per day or higher, patients treated with Zoloft required at least two dose titrations. Both Lexapro and Zoloft belong to a class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs). The study was presented in Puerto Rico at an annual meeting of neuropsychopharmacologists.

"In this study, most patients experienced relief from depressive symptoms. Patients treated with Lexapro received 10 mg throughout the study period, while patients treated with Zoloft received dosages based on depressive symptoms and the development of side effects," said George Alexopoulos, M.D., Professor of Psychiatry at Weill Medical College of Cornell University. "Lexapro is an effective treatment for depression with simple dosing that may improve patient adherence."

Each year, nearly 19 million adult Americans suffer from mild, moderate, or severe depression. One in 4 women and 1 in 10 men can expect to be diagnosed with depression during their lifetime. Depression costs the United States an estimated $44 billion each year. The World Health Organization predicts depression will become the leading cause of disability by the year 2020.

Study Conclusions<
'"/>

Contact: Charles E. Triano
212-224-6714
Forest Laboratories
10-Dec-2003


Page: 1 2 3

Related medicine news :

1. Starting beta-blocker before discharge in patients hospitalized for heart failure increases usage
2. Lexapro receives FDA approval for the treatment of generalized anxiety disorder
3. Strategy effective against drug resistant tuberculosis
4. Study shows patch therapy may be as effective as oral medications
5. Chronic pain treatments more effective when taken together, new study shows
6. Geodon effective in psychiatric emergencies; Sharply reduces time in restraints
7. Costs of antidepressants could have funded effective alternatives
8. New ways to design safer & more effective topical (transdermal) drug delivery announced in the PNAS
9. Government wasting your taxpayer money on ineffective drug cure
10. Neurobehavioral function during coma, stroke rehabilitation effective for elderly
11. European folic acid policies are not effective enough

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2017)... ... May 21, 2017 , ... Following the tragic and widely publicized ... first state to require that hospitals follow a protocol to quickly identify and treat ... as to whether such steps would have saved Rory or anyone else’s life. ...
(Date:5/19/2017)... ... May 19, 2017 , ... DMG Productions is proud ... Innovations with Ed Begley, Jr., airing fourth quarter 2017 on FOX Business. , ... organic dietary supplement made from naturally occurring ingredients. Innovations will enlighten viewers on ...
(Date:5/19/2017)... ... May 19, 2017 , ... The Miller Agency, ... to families and business owners in the region, is embarking on a cooperative ... and their families. , Multiple sclerosis (MS) is a demyelinating disease that affects ...
(Date:5/19/2017)... ... May 18, 2017 , ... ML Billing, 2016 Billing ... and sizes and specializes in large group practices, is pleased to announce their 30th ... has also set the standard in all aspects of full-service medical billing. This has ...
(Date:5/18/2017)... ... , ... Dr. Kim Ross supports Stroke Awareness Month by now accepting new ... this condition and serious systemic health conditions including heart disease and stroke. Those with ... MD, and seeking treatment with Dr. Ross immediately may prevent bacteria from spreading. ...
Breaking Medicine News(10 mins):
(Date:5/3/2017)...  Getinge, a leading global provider of products ... cost efficiency within healthcare and life sciences, today ... demonstrating that intra-aortic balloon counterpulsation (IABC) appears effective ... The single-center, retrospective, observational study showed that use ... 50cc intra-aortic balloon (IAB) in contemporary practice ...
(Date:5/2/2017)... -- George Clinical, a leading full-service CRO in the ... a Memphis -based leader in ... George Clinical has acquired Vector Oncology,s Pharma Services (CRO) Division. ... of strengthening the ability of George Clinical to ... the Asia-Pacific , the world,s ...
(Date:5/2/2017)... , May 2, 2017  Bayer today announced the ... president and head of Oncology for the company,s Pharmaceuticals ... Ashar will report to Carsten Brunn , Head ... "Bhavesh is a well-respected, results-driven leader with extensive industry ... and driving growth in oncology," said Brunn. "We are ...
Breaking Medicine Technology:
Cached News: